Most participants in trials reached 812 mg weekly, which delivered the strongest results Dosing protocols may be refined in Phase 3 and post-approval, but gradual titration will remain the standard
Yes, clinical data supports semaglutide safety for at least two years of continuous use when prescribed and monitored by a qualified physician
In the absence of crosslinking, all FcRs are incapable of signaling, except for FcIR
In fact, by continuously depriving the liver of esterified fatty acids and inhibiting the hepatic glycolytic pathway, glucagon promotes the production of ketone bodies [41,42,43] Hepatic ketogenesis is boosted as a result, and mitochondrial fatty acid oxidation is improved [14, 43]
Lets keep the discussion going in the comments below